Bicara (BCAX) Q4 2025 Earnings Transcript
Source: Motley Fool
2026-06-01 12:13:09 ET
Image source: The Motley Fool.
Monday, May 11, 2026 at 8:30 a.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Bicara Therapeutics Inc.
NASDAQ: BCAX
BCAX Trading
-1.72% G/L:
$28.265 Last:
264,146 Volume:
$28.535 Open:
BCAX Latest News
July 02, 2026 08:30:00 am
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 13, 2026 01:21:24 am
What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors?
$817,548,781
24,302,552
0.5%
33
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
